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INTRODUCTION: Level T4 video-assisted thoracoscopic sympathectomy proved superior to T3-T4 treatment for controlling 
axillary hyperhidrosis at the initial and six-month follow-ups of these patients. 
OBJECTIVE: To compare the results of two levels of sympathectomy (T3-T4 vs. T4) for treating axillary sudoresis over one year 
of follow-up. 
METHODS: Sixty-four patients with axillary hyperhidrosis were randomized to denervation of T3-T4 or T4 alone and followed 
prospectively. All patients were examined preoperatively and were followed postoperatively for one year. Axillary hyperhidrosis 
treatment was evaluated, along with the presence, location, and severity of compensatory hyperhidrosis and self-reported quality 
of life.
RESULTS: According to patient reports after one year, all cases of axillary hyperhidrosis were successfully treated by surgery. 
There were no instances of treatment failure. After six months, compensatory hyperhidrosis was present in 27 patients of the 
T3-T4 group (87.1%) and in 16 patients of the T4 group (48.5%). After one year, all T3-T4 patients experienced some degree of 
compensatory hyperhidrosis, compared to only 14 patients in the T4 group (42.4%). In addition, compensatory hyperhidrosis was 
less severe in the T4 patients (p < 0.01). Quality of life was poor before surgery, and it improved in both groups at six months and 
one year of follow-up (p = 0.002). There were no cases of mortality, no significant postoperative complications, and no need for 
conversion to thoracotomy in either group.
CONCLUSION: Both techniques were effective for treating axillary hyperhidrosis, but the T4 group showed milder compensatory 
hyperhidrosis and greater patient satisfaction at the one-year follow-up.
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INTRODUCTION
Axillary hyperhidrosis is an important disease that 
may cause serious emotional and work-related problems. 
Local treatment and psychotherapy show low effectiveness. 
Injections of botulinum toxin offer good but temporary 
results lasting fewer than six months, and excision/resection 
of the eccrine sweat glands is less effective and allows for a 
higher recurrence rate than sympathectomy.1-5
Video-assisted thoracic sympathectomy (VATS) is 
a recognized procedure for the definitive treatment of 
palmar hyperhidrosis, but its efficacy in treating axillary 
hyperhidrosis remains controversial. No randomized, 
prospective studies of axillary hyperhidrosis treatment 
have been published that compare different levels of 
thermoablation of the sympathetic chain in VATS.
Therefore, we carried out a randomized, prospective study 
to compare the results of VATS at two resection levels, T3-
T4 versus T4. Efficacy of axillary hyperhidrosis treatment, 
presence and severity of compensatory hyperhidrosis, 
and patient satisfaction were evaluated over one year 772
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after the surgery using an interview and a quality-of-life 
questionnaire.
METHODS
After randomization, 64 patients with pure axillary 
hyperhidrosis, ranging in age from 17 to 46 years, were 
submitted to VATS. All patients received information regarding 
risks and chances of compensatory hyperhidrosis. Criteria for 
inclusion in the study were a complaint of axillary hyperhidrosis 
and the intention to undergo surgery. Criteria for exclusion were 
the existence of prior thoracic surgery; the existence of diseases 
such as cardiac diseases, pulmonary infections, neoplasia, or 
pleural or lung diseases that could increase surgical risk; or a 
body mass index (BMI) greater than 25.6,7
All patients were submitted to surgery under general 
anesthesia with selective intubation and pulmonary ventilation. 
Two incisions were made in each hemithorax: the first at the 
fourth intercostal space on the anterior axillary line, and the 
second at the third intercostal space on the mid-axillary line.8,9
After  identification  of  each  sympathetic  chain, 
patients randomized into the T3-T4 group underwent 
sympathicotomy on the bodies of the third, fourth, and fifth 
ribs, followed by thermoablation of the segments isolated 
between them. Patients randomized into the T4 group 
underwent resection of the chain (sympathicotomy) at the 
fourth and fifth ribs, with thermoablation of the segment 
between them. After the sympathectomy, the lung was re-
expanded under direct viewing and air was simultaneously 
aspirated from the pleural space using a small catheter (16 
Fr). The same procedure was carried out on the contralateral 
chain. There was no routine use of a chest drain. A chest 
x-ray was performed following the operation in order to 
assess lung expansion. 
Patients were followed for one year after intervention. 
At 12 months after the index procedure, systematic 
reexaminations were performed on all patients. The 
observers recording the findings were blinded to patients’ 
treatments. The following were assessed:
1. Presence or absence of axillary hyperhidrosis reported 
by the patient and confirmed by the examiner.
2. Presence or absence of compensatory hyperhidrosis, 
along with its location and severity, as reported by the 
patient and confirmed by the examiner. The severity of the 
sudoresis was graded at one of three levels: mild, moderate, 
or severe. Patients who noticed no difference in the location 
or intensity of their body sweat were deemed unaffected 
by compensatory hyperhidrosis. Mild compensatory 
sweating was considered present when patients reported 
minor modifications in the location and severity of their 
perspiration, such as visible sweating, but did not express 
significant concern about it. Moderate compensatory 
hyperhidrosis was considered present when patients reported 
visible and embarrassing sweating or occasionally disabling 
situations caused by sweating.
Finally, severe compensatory hyperhidrosis was 
considered present when patients reported interference in 
their social and professional activities, such as the need 
for successive clothing changes caused by sweating of the 
same intensity as their previous axillary hyperhidrosis, but 
at other primary locations. It was defined as severe when it 
was visible, embarrassing, and led to at least one change of 
clothes during the day. 
3. The patients’ satisfaction with the final outcome 
of the procedure (including both the treatment and any 
complications) was subjectively evaluated using a multiple-
choice subjective rating scale (four options): 1, deficient 
(dissatisfied); 2, fair; 3, very good; 4, excellent.
STATISTICAL ANALYSIS
For categorical variables, depending on the sample, 
the χ2 or Fisher’s exact tests were used for verifying 
associations between the type of surgery and possible results 
and complications. These statistical tests were used at each 
follow-up assessment to compare types of surgery with 
the variables of interest (axillary hyperhidrosis, incidence 
and severity of compensatory hyperhidrosis, and patient 
satisfaction). The associations between patients’ ages, 
degrees of satisfaction, and ganglion resection level (T3-T4 
or T4) were investigated using the Mann-Whitney U test. 
Significance for all tests was defined at 5%.
RESULTS
The mean age and gender distributions in the two 
groups were similar (Table 1). The incidence and severity 
of compensatory hyperhidrosis are presented in Table 2. 
No recurrence of axillary hyperhidrosis was reported at the 
12-month follow-up in either of the groups. 
The incidence of compensatory hyperhidrosis was lower 
in the T4 group, at one month, six months, and 12 months 
of follow-up. Compensatory hyperhidrosis was less severe 
in the T4 group, and this group showed no cases of severe 
compensatory hyperhidrosis by the final follow-up at 12 
months.
Table 1 - Clinical characteristics of the patient sample
T3-T4 group T4 group p value
Mean age 25.06 26.67
Men/Women 10/21 4/29 0.051773
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The incidence and severity of compensatory hyperhidrosis 
in patients who underwent T3-T4 resection remained 
constant over the 12 months of follow-up, whereas both 
the incidence and severity of compensatory hyperhidrosis 
decreased in the T4 group from six to 12 months (p > 0.05). 
There was no difference in the location of compensatory 
hyperhidrosis between the two groups: the most affected 
regions were the abdomen, back, and legs. The groups also 
reported no difference in the situations that triggered the 
compensatory hyperhidrosis: the majority of patients in both 
groups (21 in the T3-T4 group, 12 in the T4) attributed it to 
heat and intense physical activity. 
The reports of patient satisfaction are presented in Table 
3. Patients of the T4 group reported higher satisfaction than 
those of the T3-T4 group (p < 0.05). It should be emphasized 
that, after one year, none of the patients in the T4 group 
were dissatisfied, but five patients in the T3-T4 group were 
dissatisfied.
DISCUSSION
Despite current local and systemic therapeutic modalities, 
axillary hyperhidrosis is still a frequent condition that affects 
a great number of patients, leading to disturbances in social 
and professional life.2,3,6,10
Previous studies have shown that VATS is an effective 
treatment for axillary hyperhidrosis, with a success rate of 
89%.11,12 As a result of technical advances and a procedural 
change such that resection is carried out at a lower ganglion 
level (fourth ganglia), the technique now has a success rate of 
94%.13 In the present study, we observed that both T3-T4 and 
T4 resections were effective in all cases at both one month and 
12 months of follow-up. We attribute this success rate to the 
extreme care taken in identifying patients who would benefit 
the most from surgical treatment, and accepting them for 
treatment only after they had received an adequate explanation 
of all the risks and of the possibility of compensatory 
hyperhidrosis and still expressed a desire to undergo surgery. 
This approach meant that only the patients best suited to the 
procedure and its aftermath were admitted for treatment. 
One problem found in several case series is the degree 
of recurrent axillary hyperhidrosis, which has been reported 
to range from 15%15 to 65%.16,17 In our study, we did not 
observe any recurrence in either group at six or 12 months 
follow-up. This lack of recurrence is probably due to the 
absence of technical failure among the operated patients.18 
The compensatory hyperhidrosis observed in this study 
was distributed in the body in the same way as described 
in the medical literature, i.e. in the abdomen, back, feet, 
and gluteal region. In most cases, it is tolerable and does 
not lead to social disturbances or occupational disability 
since the patients have been previously informed about this 
possibility. Patients are inconvenienced only when their 
symptoms are severe or when they do not receive adequate 
preoperative information. It is very important that patients 
always be warned about this possible complication before 
surgery, because of the irreversibility of the method and the 
likelihood of compensatory hyperhidrosis. 
The key to these good outcomes observed in this study 
are the resection of the T4 ganglion and information given to 
patients.19 T5 resection is not necessary.11,19 For T4 ganglion 
resection, a complete operation on T4 is necessary, involving 
sympathicotomy from the upper margin of the fourth rib to 
the lower margin of the fifth rib, followed by thermoablation 
of the chain.20 Patient satisfaction at six months follow-up 
was greater in this group than in the T3-T4 group.18,21,22 The 
high satisfaction in the T4 group increased even more at 12 
months follow-up.
Compensatory hyperhidrosis is the most frequent 
complication of VATS , and it occurs when an ample resection 
of the sympathetic chain is performed, at a frequency of up 
to 89% of cases.21-24 In our series, in which resections were 
carried out at lower levels, we found that 93.5% of the patients 
in the T3-T4 group and 57.6% in the T4 group experienced 
this complication after one year; 35.5% of the T3-T4 patients 
showed moderate or intense compensatory hyperhidrosis, 
whereas only one patient (12.5%) in the T4 group showed 
moderate compensatory hyperhidrosis. In addition, the T4 
group showed no cases of intense compensatory hyperhidrosis. 
With respect to mild compensatory hyperhidrosis, we observed 
that between the six-month and one-year follow-up of the T3-
Table 3 - Patient satisfaction rates
Group 6 months 1 year
Mean Rank Sum of Ranks  Mean Rank Sum of Ranks
T3-T4 26.79 830.50 26.73 828.50
T4 37.86 1249.50 37.92 1251.50
p < 0.002* 0.002*
*Based on the Mann-Whitney test, using asymptotic two-tailed signifi-
cance.
Table 2 – Incidence and severity of compensatory hyperhidro-
sis in the two patient groups following surgery
Group 6 months 1 year
Absent Mild Moderate/
Severe
Absent Mild Moderate/
Severe
T3-T4 4 16 11 2 18 11
T4 17 14 2 19 13 1
p < 0.001* p < 0.001*
*Based on the chi-squared test.774
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T4 group, there was an increase in mild cases (from 16 to 
18) and a decrease in the more serious cases, although the 
changes were not statistically significant. In contrast, the T4 
group showed a decrease in the number of mild cases (from 
14 to 13) since many patients started to feel that they were free 
from these effects.
We did not use any objective measurement of sudoresis 
because these methods produce only data at a specific 
point in time. There are no methods capable of measuring 
hyperhidrosis over an entire day.
Despite the presence of compensatory hyperhidrosis, 
all the patients of our series reported that the procedure had 
improved their quality of life. The satisfaction was high 
in both groups, with no statistical difference between the 
groups at either one-month or six-month follow-ups.
Long-term follow-up of these two groups may show 
whether these results persist. In the event of late recurrence 
of symptoms among patients in the T4 group, reoperation 
could be carried out in order to extend the sympathectomy 
to the T3 ganglion.25-27
CONCLUSION
We conclude that resection of the T4 ganglion is preferable 
to resection of the T3 and T4 ganglia together. Despite their 
equal efficacy for reducing axillary hyperhidrosis, T4 resection 
leads to a lower rate of compensatory hyperhidrosis.
Compensatory hyperhidrosis in the T4 group tended to 
decrease over time, which was reflected in the statistically 
significant improvement in long-term personal satisfaction.28
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